Analogue-based drug discovery III / (Record no. 206390)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05275cam a2200733Ii 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn826637765 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20171112083120.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130204t20132013gw ac ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527651085 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 352765108X |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527651115 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 352765111X |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781299241206 |
| Qualifying information | (MyiLibrary) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1299241204 |
| Qualifying information | (MyiLibrary) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783527330737 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 3527330739 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000050562533 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000053030546 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DKDLA |
| System control number | 820120-katalog:000655918 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | NLGGC |
| System control number | 382514440 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 15340091 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV043395341 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)826637765 |
| Canceled/invalid control number | (OCoLC)828869678 |
| -- | (OCoLC)828896125 |
| -- | (OCoLC)961601655 |
| -- | (OCoLC)962705463 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 455370 |
| Source of stock number/acquisition | MIL |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DG1 |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | DG1 |
| Modifying agency | EBLCP |
| -- | N$T |
| -- | MHW |
| -- | YDXCP |
| -- | COO |
| -- | IDEBK |
| -- | E7B |
| -- | NOC |
| -- | OCLCF |
| -- | IUL |
| -- | SCB |
| -- | OCLCQ |
| -- | CDX |
| -- | NKT |
| -- | OCLCQ |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM301.25 |
| Item number | .A53 2013 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 023000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 058170 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 072000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | HEA |
| Source | eflch |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1/9 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Analogue-based drug discovery III / |
| Statement of responsibility, etc. | edited by János Fischer, C. Robin Ganellin, David P. Rotella. |
| Medium | [electronic resource] |
| 246 3# - VARYING FORM OF TITLE | |
| Title proper/short title | Analogue-based drug discovery 3 |
| 246 3# - VARYING FORM OF TITLE | |
| Title proper/short title | Analog-based drug discovery III |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Weinheim : |
| Name of producer, publisher, distributor, manufacturer | Wiley-VCH, |
| Date of production, publication, distribution, manufacture, or copyright notice | [2013] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xviii, 385 pages) : |
| Other physical details | illustrations, portraits |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE | |
| Title | General Aspects. Pioneer and Analogue Drugs / |
| Statement of responsibility | Janos Fischer, C Robin Ganellin, David P Rotella -- |
| Title | Competition in the Pharmaceutical Drug Development / |
| Statement of responsibility | Christian Tyrchan, Fabrizio Giordanetto -- |
| Title | Metabolic Stability and Analogue-Based Drug Discovery / |
| Statement of responsibility | Amit S Kalgutkar, Antonia F Stepan -- |
| Title | Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders / |
| Statement of responsibility | Mark L Peterson, Hamid Hoveyda, Graeme Fraser, Eric Marsault, Rene Gagnon -- |
| Title | Drug Classes. The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes / |
| Statement of responsibility | A Ganesan -- |
| Title | Thienopyridyl and Direct-Acting P2Y Receptor Antagonist Antiplatelet Drugs / |
| Statement of responsibility | Joseph A Jakubowski, Atsuhiro Sugidachi -- |
| Title | Selective Estrogen Receptor Modulators / |
| Statement of responsibility | Amarjit Luniwal, Rachael Jetson, Paul Erhardt -- |
| Title | Discovery of Nonpeptide Vasopressin V2 Receptor Antagonists / |
| Statement of responsibility | Kazumi Kondo, Hidenori Ogawa -- |
| Title | The Development of Cysteinyl Leukotriene Receptor Antagonists / |
| Statement of responsibility | Peter R Bernstein -- |
| Title | Case Studies. The Discovery of Dabigatran Etexilate / |
| Statement of responsibility | Norbert Hauel, Andreas Clemens, Herbert Nar, Henning Priepke, Joanne van Ryn, Wolfgang Wienen -- |
| Title | The Discovery of Citalopram and Its Refinement to Escitalopram / |
| Statement of responsibility | Klaus P Bogeso, Connie Sanchez -- |
| Title | Tapentadol : From Morphine and Tramadol to the Discovery of Tapentadol / |
| Statement of responsibility | Helmut Buschmann -- |
| Title | Novel Taxanes: Cabazitaxel Case Study / |
| Statement of responsibility | Herve Bouchard, Dorothee Semiond, Marie-Laure Risse, Patricia Vrignaud -- |
| Title | Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design / |
| Statement of responsibility | Srikanth Venkatraman, Andrew Prongay, George F Njoroge -- |
| Title | A New-Generation Uric Acid Production Inhibitor: Febuxostat / |
| Statement of responsibility | Ken Okamoto, Shiro Kondo, Takeshi Nishino. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and--together with the previous volumes--constitutes the first systematic approach to drug analogue development"--Publisher's website. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Online resource; title page from PDF title page (viewed June 30, 2014). |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug development. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Drug Guides. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Nursing |
| -- | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacy. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug development. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst00898670 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | local |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fischer, János, |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ganellin, C. R. |
| Fuller form of name | (C. Robin), |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rotella, David P., |
| Relator term | editor. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Title | Analogue-based drug discovery III. |
| Place, publisher, and date of publication | Weinheim : Wiley-VCH, [2013] |
| International Standard Book Number | 9783527330737 |
| Record control number | (OCoLC)825555931 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://onlinelibrary.wiley.com/book/10.1002/9783527651085 |
| Public note | Wiley Online Library |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Books |
No items available.